Evidence map›Paper›PMID 42355176›Full record

ArticleMaterials (Basel, Switzerland)2026

Preparation and Application of a Novel Anti-Contamination Agent for Use in Drilling Fluids.

Song Zhang, Xi Guan, Fei Deng, Xiaowei Cheng

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Song ZhangChuanqing Drilling Engineering Co., Ltd., Drilling Fluid Technology Services Company, Chengdu 610051, China.
Xi GuanSchool of New Energy and Materials, Southwest Petroleum University, Chengdu 610500, China.
Fei DengSchool of New Energy and Materials, Southwest Petroleum University, Chengdu 610500, China.
Xiaowei ChengSchool of New Energy and Materials, Southwest Petroleum University, Chengdu 610500, China.ORCID 0000-0002-7975-7254

Funding

Science and Technology Project of CNPC Chuanqing Drilling Engineering Company Limited CQ2025B-6-5-3
6 · The paper itself

Abstract

An anti-contamination agent (Zn/Al-ATMP-LDH) was synthesized by intercalation and used to correct the abnormal thickening and related operational risks caused by contact contamination between drilling fluids and cement slurries during high-temperature/high-pressure cementing. The experimental results show that the agent is chemically stable and exhibits good compatibility with conventional spacer fluid additives. When compared with the direct addition of amino tris(methylenephosphonic acid) (ATMP), confining ATMP within a layered double hydroxide (LDH) markedly mitigates the retarding effect. At a dosage exceeding 0.3 wt%, the compressive strength of cement stone increased from 0 to 32.84 MPa following curing at 90 °C for 1 day and continued to develop steadily after 7 days. Following conditioning at 187 °C and 145 MPa for 120 min, the spacer system formulated using the proposed agent as the core component served to enhance the rheology of the mixed slurry via synergistic adsorption-regulation-dispersion stabilization-controlled release. The mixed slurry maintained stable rheological properties before and after aging with no uncontrolled thickening. When mixing the cement slurry and drilling fluid at a 7:3 volume ratio, the slurry consistency exceeded 60 Bc within 1 h, failing to meet operational requirements. In contrast, the mixed slurry containing the anti-contamination spacer (cement slurry-drilling fluid-spacer = 7:2:1) exhibited a thickening time greater than 300 min and was successfully applied in field-cementing operations in a well in the Gaomo area.

Indexed as

anti-contamination agentcompatibilitydrilling fluidlayered double hydroxide (LDH)spacer fluid

Identifiers

PMID42355176
PMCPMC13303198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.